PHL-VALPROIC ACID E.C. DIN 02260662
Health Canada record
| Active ingredient(s) | VALPROIC ACID 500 MG |
|---|---|
| Dosage form | Capsule (Enteric-Coated) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AG01 VALPROIC ACID |
| Original market date | 06-Dec-2004 |
| Current status date | 25-Oct-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmel Inc. — licence 101409, not currently licensed, last inspection rating C (2018-01-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VALPROIC ACID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02238048 | APO-VALPROIC ACID | APOTEX INC | Capsule | VALPROIC ACID 250 MG | Marketed |
| 02230768 | PMS-VALPROIC ACID | PHARMASCIENCE INC | Capsule | VALPROIC ACID 250 MG | Marketed |
| 02237830 | VALPROIC ACID | APOTEX INC | Capsule | VALPROIC ACID 250 MG | Approved |
| 00507989 | DEPAKENE CAP 500MG | ABBOTT LABORATORIES, LIMITED | Capsule (Enteric-Coated) | VALPROIC ACID 500 MG | Cancelled Post Market |
| 02231030 | DOM-VALPROIC ACID | DOMINION PHARMACAL | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
| 02231031 | DOM-VALPROIC ACID E.C. | DOMINION PHARMACAL | Capsule (Enteric-Coated) | VALPROIC ACID 500 MG | Cancelled Post Market |
| 02238448 | FTP-VALPROIC ACID | FTP-PHARMACAL INC. | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
| 02184648 | MYLAN-VALPROIC | MYLAN PHARMACEUTICALS ULC | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
| 02218321 | NOVO-VALPROIC | TEVA CANADA LIMITED | Capsule (Enteric-Coated) | VALPROIC ACID 500 MG | Cancelled Post Market |
| 02100630 | NOVO-VALPROIC | TEVA CANADA LIMITED | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
| 02231248 | PENTA-VALPROIC CAPSULES | PENTAPHARM LTD. | Capsule | VALPROIC ACID 250 MG | Cancelled (Unreturned Annual) |
| 02260654 | PHL-VALPROIC ACID | PHARMEL INC | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
| 02229628 | PMS-VALPROIC ACID E.C. | PHARMASCIENCE INC | Capsule (Enteric-Coated) | VALPROIC ACID 500 MG | Dormant |
| 02231489 | RATIO-VALPROIC | TEVA CANADA LIMITED | Capsule (Enteric-Coated) | VALPROIC ACID 500 MG | Cancelled Post Market |
| 02217414 | RATIO-VALPROIC | TEVA CANADA LIMITED | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
| 02140055 | RATIO-VALPROIC - ECC 500MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Capsule (Enteric-Coated) | VALPROIC ACID 500 MG | Cancelled Post Market |
| 02140047 | RATIO-VALPROIC-CAP 250MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
| 02239713 | SANDOZ VALPROIC | SANDOZ CANADA INCORPORATED | Capsule (Enteric-Coated) | VALPROIC ACID 500 MG | Cancelled Post Market |
| 02239714 | SANDOZ VALPROIC | SANDOZ CANADA INCORPORATED | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
| 02238546 | VALPROIC-250 | PRO DOC LIMITEE | Capsule | VALPROIC ACID 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 5909 | 2004-11-17 | New Drug Submission (NDS) | NEW MANUFACTURER AND PRODUCT NAME |
International API supply for VALPROIC ACID
7 valid EDQM Certificates of Suitability from 7 holders. 10 active FDA Drug Master Files.
Request a quote for PHL-VALPROIC ACID E.C.